India, Jan. 29 -- The shares of this company, which is a part of the Piramal group of companies and operates through 3 major segments: first, the Contract Development and Manufacturing Organisations (CDMO); second, the Complex Hospital Generics; and third, consumer healthcare, had its shares in focus after the company reported disappointing Q3 results; however, the shares still jumped 4%. Here's the reason why.

With the market cap of Rs 21,281 crore, the shares of Piramal Pharma Ltd have jumped 4% and reached a high at Rs 163.20, compared to their previous day's closing price of Rs 154.25. The shares have an ROCE and ROE of 6.45% and 1.11%, respectively.

Q3 Result highlights The revenue from operations for the company stood at Rs 2,140...